-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Aquestive Therapeutics (AQST)
-
-
-
-
-
-
-
Aquestive Therapeutics receives patents for Anaphylm extending protection to 2037
-
-
-
-
-
-
-
Aquestive schedules Health Canada meeting for Anaphylm drug submission
-
-
-
-
-
-
-
Aquestive Therapeutics Inc. (AQST) Announces Positive Topline PK Results from its Pediatric Study and Completes the NDA Submission for Anaphylm Sublingual Film
-
-
-
-
-
-
-
Aquestive Therapeutics (AQST) Receives FDA Orphan Drug Exclusivity for Libervant Buccal Film
-
-
-
-
-
-
-
Aquestive Therapeutics Inc. (AQST) Announces Positive Topline Results from Oral Allergy Syndrome Challenge Study for Anaphylm Sublingual Film
-
-
-
-
-
-
-
Aquestive Therapeutics (AQST) PT Lowered to $7 at Lake Street Capital Markets
-
445,853 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

